fowlerat

Anticancer Bioscience: A Precision Therapeutics Company Dedicated to Discovering and Developing Breakthrough Cancer Therapies for Unmet Oncology Needs Around the World

I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Anticancer Bioscience Has Been Named as One of the ‘50 Most Admired Companies Of The Year 2021’ By The Silicon Review

Press Releases / By fowlerat

PRESS RELEASEChengdu, China, October 25, 2021Anticancer Bioscience Has Been Named as One of the ‘50 Most Admired Companies Of The Year 2021’ By The Silicon Review Chengdu, China, October 25, 2021 - Anticancer Bioscience (ACB), pioneers in synthetic lethal approaches to precision oncology, has been named as one of the ‘50 Most Admired Companies of …

Anticancer Bioscience Has Been Named as One of the ‘50 Most Admired Companies Of The Year 2021’ By The Silicon Review Read More »

Anticancer Bioscience Welcomes New Investor into Seed Financing Round Bringing Total Raised to Over $31M to Advance Synthetic Lethality Approaches to Cancer Therapy

Press Releases / By fowlerat

PRESS RELEASEChengdu, China, October 14, 2021Anticancer Bioscience Welcomes New Investor into Seed Financing Round Bringing Total Raised to Over $31M to Advance Synthetic Lethality Approaches to Cancer Therapy Chengdu, China, October 14, 2021 - Anticancer Bioscience (ACB), pioneers in synthetic lethal approaches to precision oncology, announced today that it had secured an additional CNY 68.4 …

Anticancer Bioscience Welcomes New Investor into Seed Financing Round Bringing Total Raised to Over $31M to Advance Synthetic Lethality Approaches to Cancer Therapy Read More »